LifeMD, Inc. (LFMD)
NASDAQ: LFMD · Real-Time Price · USD
4.130
-0.070 (-1.67%)
At close: Jun 26, 2026, 4:00 PM EDT
4.111
-0.019 (-0.47%)
After-hours: Jun 26, 2026, 7:52 PM EDT

Company Description

LifeMD, Inc. operates as a direct-to-patient telehealth company, engages in the provision of patients access to virtual medical care and pharmacy services in the United States.

It offers telehealth platform comprising Rex MD, a men’s telehealth platform that provides virtual diagnosis, treatment, and prescription medications for men’s health conditions, including erectile dysfunction, premature ejaculation, hair loss, insomnia, weight loss, and performance anxiety; and ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss.

The company also provides LifeMD PC, a virtual primary care and telehealth service which is a provider for their primary care, urgent care, and chronic care needs; and offers virtual medical care, including on-demand consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, integration with in-home tools, and more.

In addition, it offers GLP-1 for weight management and in-home health monitoring devices. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021.

LifeMD, Inc. was founded in 1994 and is headquartered in New York, New York.

LifeMD, Inc.
LifeMD logo
Country United States
Founded 1994
Industry Health Information Services
Sector Healthcare
Employees 352
CEO Justin Schreiber

Contact Details

Address:
236 Fifth Avenue, Suite 400
New York, New York 10001
United States
Phone 866 351 5907
Website lifemd.com

Stock Details

Ticker Symbol LFMD
Exchange NASDAQ
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
CIK Code 0000948320
CUSIP Number 53216B104
ISIN Number US53216B1044
Employer ID 76-0238453
SIC Code 8011

Key Executives

Name Position
Justin Schreiber Chairman and Chief Executive Officer
Shayna Webb Dray Chief Operating Officer
Stefan Galluppi Chief Innovation Officer
Atul Kavthekar Chief Financial Officer
Maria E. Stan CPA Chief Accounting Officer and Controller
Umesh Sripad Chief Technology Officer
Eric H. Yecies Chief Legal Officer, General Counsel and Corporate Secretary
Shane Biffar Chief Compliance Officer and Deputy General Counsel
Chris Pisano Chief Marketing Officer
Nicholas P. Alvarez Chief Acquisition Officer and Head of Customer Acquisition

Latest SEC Filings

Date Type Title
Jun 22, 2026 8-K Current Report
May 6, 2026 10-Q Quarterly Report
May 6, 2026 8-K Current Report
Apr 30, 2026 ARS Filing
Apr 30, 2026 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Apr 30, 2026 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Apr 30, 2026 DEF 14A Other definitive proxy statements
Apr 1, 2026 S-8 Securities to be offered to employees in employee benefit plans
Mar 23, 2026 144 Filing
Mar 18, 2026 8-K Current Report